On February 10, Karsten Munk Knudsen, Chief Financial Officer of the Danish pharmaceutical company Novo Nordisk, sold 26,557 shares in the company. The shares were sold at a price of DKK 315.60 per share, amounting to a total transaction of DKK 8.4 million. This information was disclosed in an insider notification.

Following the sale, Munk Knudsen holds 238,828 shares in the company, according to the shareholder service Holdings.